A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene-and monophasic desogestrel-containing oral contraceptives

Gynecological Endocrinology

Volumn 10, Issue SUPPL. 5, 1996, Pages 33-41

  Lacante, P ^a  

^a Wyeth Lederle Medical Department   (Belgium)

Author keywords

Cycle Control; Desogestrel; Monofhasic Gestodene; Oral Contraceptives; Triphasic Gestodene; Well being

Indexed keywords

EID: 0013644578     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513599609049607     Document Type: Article

References (14)

1. Rosenberg, M.J. and Long, S. C. (1992). Oral contraceptives and cycle control: a critical review of the literature. Contraception, 8 (Suppl. 1), 35
2. Rosenberg, M. and Waugh, M. (1994). Oral contraceptives and cycle control: are the new progestogens better? Med. Dial., 415
3. Latin American Oral Contraceptive Study Group (1994). Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl-estradiol and desogestrel/ethinylestradiol. Contraception, 50,201-14
4. Diisterberg, B., Beier, S., Schneider, W. H. F. and Spona, J. (1988). Pharmacological features of gestodene in laboratory animals and man. In Breckwoldt, M. and Diisterberg, B. (eds.) Gestodene, a New Direction in Oral Contraception, pp. 13-29. (Carnforth, UK: Parthenon Publishing)
5. Brill, K., Norpoth, T., Schnitker, J. and Albring, M. (1991). Clinical experience with a modern low dose oral contraceptive in almost 100,000 users. Contraception, 43, 101-10
6. Yuzpe, A. A. (1995). Triphasic levonorgestrel: its role in oral contraception. Gynecol. Endocrinol., 9 (Suppl. 2), 29-37
7. Brill, K., Muller, O, Schnitker.J. and Albring, M. (1991). The influence of difFerent low-dose oral contraceptives on intermenstrual bleeding. Adv. Contracept., 7 (Suppl. 2), 51-61
8. Moos, R. H. (1968). The development of a menstrual distress questionnaire. Psychosom. Med., 30, 853-67
9. Markum, R. (1976). Assessment of the reliability of and the effect of neutral instructions on the symptom ratings on the Moos Menstrual Distress Questionnaire. Psyclwsom. Med., 38, 163-72
10. Gruba, G. H. and Rohrbaugh, M. (1975). MMPI correlates of menstrual distress. Psychosom. Med., 37,265-72
11. Brooks J., Ruble, D. and Clark, A. (1977). College women's attitudes and expectations concerning menstrual-related changes. Psychosom. Med., 39, 288-98 (Pubitemid 8219406)
12. Paige, K. E. (1900). Effects of oral contraceptives on affective fluctuations in the menstrual cycle. Pyschosom. Med., 171, 515-37
13. Rabe, T., Maletz-Kehry, W., Leppien, G., Forrs-man, W. G., Gmeiner, C. and Runnebaum, B. (1993). Clinical update on triphasic gestodene. Gynecol. Endocrinol., 7 (Suppl.), 25-32
14. Andrade, R. P. (1993). Clinical comparison of a triphasic gestodene preparation and a monophasic desogestrel preparation. Gynecol. Endocrinol., 7 (Suppl.), 33-41